FDA Shakes Up COVID Booster Rules

Big change alert: The FDA just announced they’ll require actual clinical trials (not just immune response data) before approving new COVID booster shots for healthy people under 65. If you’re high-risk or over 65, you’ll still get access based on immune response. But for the rest of us? The bar’s higher—think gold-standard, randomized trials. Vaccine stocks like Moderna and Novavax jumped on the news. Is this the start of a new era for vaccine approvals? #COVID19 #FDA #VaccineUpdate #HealthNews #Moderna #Health